Investigational Site Number :2760006

Berlin 10787

0 studies enrolling now · 5 studies all time

What they study most

Celiac Disease, Chronic Obstructive Pulmonary Disease, Coeliac Disease, Thrombotic Thrombocytopenic Purpura, Type 2 Diabetes Mellitus

Studies at this site

• A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease — Running, not enrolling
• Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early